castle trial results
Clinicians Embrace Chronic Disease Management Gains
Clinicians Embrace Chronic Disease Management Gains CD19 CAR-T therapy can deliver sustained remission for about one-third of refractory autoimmune patients, giving clinicians a curative-style tool beyond symptom control. The CASTLE basket trial showed 30% remission, and early data suggest durability beyond a year, reshaping chronic disease pathways. Medical Disclaimer: This